Mural Oncology Statistics
Share Statistics
Mural Oncology has 17.27M
shares outstanding. The number of shares has increased by 1.8%
in one year.
| Shares Outstanding | 17.27M |
| Shares Change (YoY) | 1.8% |
| Shares Change (QoQ) | 0.98% |
| Owned by Institutions (%) | 54.96% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 866 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 657.86K, so 3.81% of the outstanding
shares have been sold short.
| Short Interest | 657.86K |
| Short % of Shares Out | 3.81% |
| Short % of Float | 3.82% |
| Short Ratio (days to cover) | 2.47 |
Valuation Ratios
The PE ratio is -0.42 and the forward
PE ratio is -1.18.
Mural Oncology's PEG ratio is
0.01.
| PE Ratio | -0.42 |
| Forward PE | -1.18 |
| PS Ratio | 0 |
| Forward PS | 0.5 |
| PB Ratio | 0.39 |
| P/FCF Ratio | -0.42 |
| PEG Ratio | 0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Mural Oncology.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.84,
with a Debt / Equity ratio of 0.06.
| Current Ratio | 5.84 |
| Quick Ratio | 5.84 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | -0.06 |
| Debt / FCF | -0.06 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,107,879.31 |
| Employee Count | 116 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -22.29% in the
last 52 weeks. The beta is 3.4, so Mural Oncology's
price volatility has been higher than the market average.
| Beta | 3.4 |
| 52-Week Price Change | -22.29% |
| 50-Day Moving Average | 2.25 |
| 200-Day Moving Average | 3.25 |
| Relative Strength Index (RSI) | 51.31 |
| Average Volume (20 Days) | 4,707,701 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -138.26M |
| Net Income | -128.51M |
| EBITDA | -125M |
| EBIT | -128.51M |
| Earnings Per Share (EPS) | -7.58 |
Full Income StatementBalance Sheet
The company has 115.46M in cash and 8.02M in
debt, giving a net cash position of 107.44M.
| Cash & Cash Equivalents | 115.46M |
| Total Debt | 8.02M |
| Net Cash | 107.44M |
| Retained Earnings | -159.37M |
| Total Assets | 132.08M |
| Working Capital | 94.5M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -128.54M
and capital expenditures -92K, giving a free cash flow of -128.64M.
| Operating Cash Flow | -128.54M |
| Capital Expenditures | -92K |
| Free Cash Flow | -128.64M |
| FCF Per Share | -7.59 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
